Literature DB >> 6283302

Neurologic complications of primary Sjögren's syndrome.

E L Alexander, T T Provost, M B Stevens, G E Alexander.   

Abstract

Although peripheral nervous system disease has been well documented in Sjögren's syndrome (SS), central nervous system (CNS) involvement is considered distinctly uncommon. Sixteen patients with primary SS and CNS disorders not attributable to other causes were the subjects of this study. Cerebral manifestations, both focal and diffuse, as well as spinal cord disease, were observed. Peripheral vasculitis occurred in 12 patients (75%), 83% of whom had anti-Ro(SSA) antibodies. The high proportion of patients with concomitant peripheral vasculitis, and the observed association with antibodies to the Ro(SSA) antigen system which, in other studies, has been linked to vasculitis in SS, suggest that an immune vasculopathy may play a role in the pathogenesis of the CNS disease of SS.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283302     DOI: 10.1097/00005792-198207000-00004

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  35 in total

Review 1.  Neurology and the skin.

Authors:  O Hurko; T T Provost
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

Review 2.  CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors:  M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Unusual presentation of Sjögren's syndrome.

Authors:  Aicha Bouraoui; Syed Farhan Bari; Julian Nash; Kenneth Dawson
Journal:  BMJ Case Rep       Date:  2014-11-20

4.  Chronic relapsing inflammatory polyneuropathy complicating sicca syndrome.

Authors:  M Gross
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

5.  Sjogren's syndrome. Its contribution to neuropsychiatric syndrome in patients with primary biliary cirrhosis.

Authors:  R E Tarter; A L Hays; J Carra; K L Edwards; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

6.  Abnormal regional cerebral blood flow on 99mTc ECD brain SPECT in patients with primary Sjögren's syndrome and normal findings on brain magnetic resonance imaging.

Authors:  C P Chang; Y C Shiau; J J Wang; S T Ho; A Kao
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

Review 7.  [Vasculopathy in Sjögren's syndrome].

Authors:  E Feist; K-G A Hermann; A Dankof
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

8.  Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain--a preliminary report.

Authors:  W S Huang; P Y Chiu; A Kao; C H Tsai; C C Lee
Journal:  Rheumatol Int       Date:  2003-02-18       Impact factor: 2.631

9.  Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.

Authors:  B Benyahia; Z Amoura; A Rousseau; C Le Clanche; A Carpentier; J C Piette; J Y Delattre
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

10.  Neurophysiological assessment of peripheral neuropathy in primary Sjögren's syndrome.

Authors:  M Denislic; D Meh
Journal:  Clin Investig       Date:  1994-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.